Amgen Inc.
GB ˙ BATS-CHIXE ˙ NL0000888691
SecurityGB:AMGD / Amgen Inc.
InstitutionCarsonAllaria Wealth Management, Ltd.
Latest Disclosed Ownership689 shares
Latest Disclosed Value $ 242,383
CarsonAllaria Wealth Management, Ltd. reports 0.44% increase in ownership of AMGD / Amgen Inc.

On April 30, 2026 - CarsonAllaria Wealth Management, Ltd. filed a 13F-HR form disclosing ownership of 689 shares of Amgen Inc. (GB:AMGD) valued at $242,383 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 686 shares of Amgen Inc.. This represents a change in shares of 0.44% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F AMGEN COM 031162100 689 3 0.44 242 8.04 0.1197
2026-01-22 2025-12-31 13F AMGEN COM 031162100 686 -38 -5.25 225 9.80 0.1114
2025-10-28 2025-09-30 13F AMGEN COM 031162100 724 23 3.28 204 4.62 0.1062
2025-07-24 2025-06-30 13F AMGEN COM 031162100 701 1 0.14 196 -10.55 0.1051
2025-04-28 2025-03-31 13F AMGEN COM 031162100 700 0 0.00 218 19.78 0.1265
2025-01-27 2024-12-31 13F AMGEN COM 031162100 700 -66 -8.62 182 -26.02 0.1045
2024-10-21 2024-09-30 13F AMGEN COM 031162100 766 -61 -7.38 247 -4.65 0.1416
2024-07-22 2024-06-30 13F AMGEN COM 031162100 827 -91 -9.91 259 -1.15 0.1582
2024-05-07 2024-03-31 13F AMGEN COM 031162100 918 -134 -12.74 261 -13.86 0.1642
2024-02-08 2023-12-31 13F AMGEN COM 031162100 1,052 -42 -3.84 303 3.06 0.2173
2023-11-09 2023-09-30 13F AMGEN COM 031162100 1,094 -10 -0.91 294 20.00 0.2390
2023-08-01 2023-06-30 13F AMGEN COM 031162100 1,104 0 0.00 245 -7.89 0.1930
2023-04-26 2023-03-31 13F AMGEN COM 031162100 1,104 6 0.55 267 0.2250
2023-02-06 2022-12-31 13F AMGEN COM 031162100 1,098 112 11.36 0 -100.00 0.2521
2022-11-09 2022-09-30 13F AMGEN COM 031162100 986 3 0.31 222 -7.11 0.2062
2022-08-02 2022-06-30 13F AMGEN COM 031162100 983 0 0.00 239 0.42 0.2232
2022-05-05 2022-03-31 13F AMGEN COM 031162100 983 12 1.24 238 8.68 0.2130
2022-02-10 2021-12-31 13F AMGEN COM 031162100 971 971 219 0.1936
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.